搜索到 1000 条关于 u72텔레그램toadDB!⊇성인pc게임디비문의ㄱㅡ 的文章

王卫忠:成人支气管扩张症诊治专家共识

2012.11.06 王卫忠:成人支气管扩张症诊治专家共识

(1)气道防御功能低下-6(2)感染和气道炎症恶性循环导致支气管扩张:-14(2)感染和气道炎症恶性循环导致支气管扩张:-72.继发性支气管扩张症的发病基础-51.支气管先天发育不全:-43.病理生理-93.病理生理-10CT表现-183.病理生理-12CT表现-20CT表现-21CT表现-19CT表现-22病理与病理生理-8成人支气管扩张症诊治专家共识-1病因诊断:-26发病机制-3非抗菌药物治疗-39非抗菌药物治疗-40咯血 ...
第九届光华工程科技奖通过初评候选人名单公示

2012.03.13 第九届光华工程科技奖通过初评候选人名单公示

2012年光华工程科技奖初评工作已经结束。从101位有效候选人中,产生进入理事会终评的候选人26位。根据《光华工程科技奖管理细则》的规定,现予公布。投诉受理截止日期2012年3月21日。工程奖(13名)姓 名年龄专业与专长工作单位初评学部张卫华50机车车辆动力学西南交通大学 牵引动力国家重点实验室机械与运载工程学部马佳光70光电子技术中国科学院光电技术研究所信息与电子工程学部赵葆常72光学工程中国科学院西安光学精密机械研究所信息与电子工程学部李东英91冶金技术原中 ...
支气管哮喘

2016.04.29 支气管哮喘

%,可诊断为激发试验阳性。通过剂量反应曲线计算使 FEV1下降 20% 的吸入药物累积剂量(PD20-FEV1)或累积浓度(PC20-FEV1),可对气道反应性...疫苗,起始浓度为 l00SQ-U/ml,每周皮下注射一次,15 周达到维持量,治疗 1-2 年,若治疗反应良好,可坚持 3-5 年。脱敏治疗的局部反应发生率约
三分钟搞定胰岛素泵速度调节

2016.04.05 三分钟搞定胰岛素泵速度调节

,我们来花个三五分钟,把胰岛素泵速度调节的精华收入大脑!1. 胰岛素泵怎么配?常规胰岛素 50U+50 mL 生理盐水,配成胰岛素泵。胰岛素静脉为即刻作用、0.5 h 最强、持续 2 h;皮下为 0.5-1 h 作用、2-4 h 最强、持续 6-8 h。2. 初始速度怎么定?如果既往应用胰岛素<30U/ 天,则为
IGF-IR tyrosine kinase signaling in hematological malignancies

2008.09.19 IGF-IR tyrosine kinase signaling in hematological malignancies

Prof. Hesham M. Amin University of Texas M.D Anderson Cancer Center, U.S.A.
TAF 有效改善慢乙肝患者肾脏功能

2020.02.26 TAF 有效改善慢乙肝患者肾脏功能

(+)、M204V(+)、S202 G(+),换用替诺福韦脂(TDF)抗病毒治疗,服用 TDF 前查血肌酐 72μmol/L,eGFR 93.06 ml/min·1.73m2...、原发性肝癌,1 个弟弟患慢性乙型肝炎。入院时(2019.3.28)查生化 ALT 32U/L、AST49U/L、TBIL67μmol/L、血肌酐 100μmol/L

2012.09.19 首届“中国国际药品安全与质量控制大会”

中国国际药品安全与质量控制大会

2011首届&ldquo;药安大会&rdquo; 各有关单位:

药品质量安全是全球药品行业面临的最大挑战之一,而且需要政府、企业单位及相关机构共同努力,协助解决药品安全面临的各种问题。此外,确保药品质量安全还需要更高的透明度、更好的信息共享、以及政府、业界和学术界之间更好的协作和对话。为了创造这样的机会、不断提高药品质量,保障公众用药安全、及促进我国医药事业的良性发展,由北京中培科检信息技术中心主办以&ldquo;技术与创新同步、法律与责任通行&rdquo;为主题的&ldquo;2011中国国际药品安全与质量控制大会&rdquo;,定于2011年5月25日-26日在北京召开。欢迎广大从事药物研发、生产、检验、分析、药品质量管理及相关技术企业参与。希望通过举办本次大会,为确保民众更健康有效的用药安全,深入探讨,加强合作,提出有价值的意见建议,加快我国医药产业发展做出积极贡献。本次大会的重点围绕我国药品产业质量安全的解决方案,旨在搭建一个药品产业技术与方案相互交流的公共平台。大会主要内容包括主题论坛、行业展览、专题研讨会三个部分组成。邀请各大制药企业代表、中国政府高级官员、国外驻华机构代表、中外著名专家学者、各地方药检机构代表等共同参会研讨,为积极应对未来药品安全面临的新挑战献计献策。相信在各方共同努力之下,这将是一次促进国际药品安全学术交流的盛会,也是推广药品安全应用技术与解决方案的最佳平台。

大会目的:加强技术领域合作,保障民众用药安全,以药品安全良性发展为立足点,探讨并把握当前最新解决方案与先进技术

大会主题:技术与创新同步法律与责任同行

大会地点:北京新世纪日航饭店

大会时间:2011年5月25-26日

大会网站:www.drug-china.com

大会规模:50余家产品与解决方案供应商 500余位医药行业嘉宾

大会特色:主题演讲,专题讨论,产品展示

一、大会主要内容1国家药品安全管理政策与最新动态2药品安全在未来全球市场中面临的挑战3药品安全的未来对药品工业的意义4政府、行业组织及第三方机构在药品安全危机中的作用5生产过程药品安全的解决方案6相关技术与方案在药品质量控制中的应用7药品质量分析的最新技术与方案探讨8药品安全快速检测技术和产品的研究发展9药用辅料质量管理和应用技术10药品安全包装和储运技术的研究发展11药品安全的风险监测评估和药品安全标准二、专题研讨专题一.药品安全分析与检测技术专题二. 药品安全的质量控制与解决方案专题三. 药用辅料质量管理与新技术应用专题四. 药品包装、流通领域质量控制技术专题五.制药企业—技术创新之道

三、参会对象

  • 中外制药企业董事长、总经理、副总经理、药品质量授权人、产品放行责任人;
  • 中外制药企业研发总监、技术总监、质量(QA/QC)总监、实验室主管;
  • 中外制药企业生产管理部长、品控部经理、产品法规经理;
  • 药品安全检测仪器设备研发生产、代理商;信息技术服务商;
  • 高校药学院、医学院、生命科学院实验室主管;
  • 国内外从事新药研发与创新的研发公司、技术服务机构中高层管理人员和项目负责人。
  • 公共卫生与医疗机构、科研机构、媒体记者。

四、参展范围

  • 实验室分析检测仪器设备; 药物安全快速检测仪器试剂;
  • 药物安全消毒与杀菌设备; 药物金属异物检测仪器设备;
  • 工厂卫生标准检测等仪器设备;药品安全包装与储运设备;
  • 药品安全追溯与系统软件; 药典分析仪器,药物成份分析仪器;
  • 化学分析及生物分析产品; 药物安全综合技术与解决方案等。
因会场所设展位数量不多,如需预定展位请从速,展位安排请垂询组委会。

五、合作商机
1、大会演讲:本次大会除特邀嘉宾外,还为中外有关制药企业、仪器设备厂商等提供特别演讲机会,欢迎围绕大会主题及技术专题论坛中涉及的各项议题自荐或举荐合适演讲题目和专家。
2、展示与推介:大会现场特设立企业技术、产品、服务及企业品牌、形象展示与交流展台及赞助商新产品推荐会,名额有限,请从速预定。
3、协办和赞助:热忱欢迎中外制药企业、仪器设备厂商及其他相关机构为大会提供各种形式的赞助活动,携手紧密合作、共襄大会盛举,我们将为协办(赞助)单位提供丰厚回报,详情敬请垂询。六、支持媒体生物谷升技网化学分析网中国色谱网中国分析仪器网分析测试百科网中国生物器材网

中国化学仪器网中国化工仪器网 信息仪器网 中国质检仪器装备网等七、联系方式2011首届&ldquo;药安大会&rdquo;组委会Tel:010-84840335 84840448

E-mail:drug_china@163.com

http://www.drug-china.com

2012.09.19 【免注册费】上海分子流行病学与GWAS会议国际研讨会

分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析(GWAS)为全面系统研究复杂疾病的遗传因素掀开了新的一页,为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因,我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了&ldquo;常见重大疾病全基因组关联分析和药物基因组学研究&rdquo;的863重点项目,吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员,特别是广大研究生了解GWAS的研究原理和方法,学会设计GWAS的研究和分析实验结果,同时在癌症领域分享海内外研究专家们的成功经验,并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加,请有意者及时将回执返回联系邮箱。免注册费(食宿餐饮费用自理)。名额有限,报名从速!时间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆 上海市邯郸路220号,200433
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹 高歌 联系电话: 021-55664495
回执邮箱: GWAS2009@gmail.com
BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives&bull; To better understand the potential applications of GWAS
&bull; To address practical issues in study design, implementation, and data analysis of GWAS
&bull; To promote interaction and collaboration among researchers who are interested in GWAS
&bull; To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
&bull; To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
&bull; Breast cancer in Chinese populations Xiao-ou Shu
&bull; Genetic association studies of skin cancer Jiali Han
&bull; Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
&bull; Genetic association studies of lung cancer in Chinese populations Daru Lu
&bull; Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
&bull; Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
&bull; Genetic association studies of hypertension in Chinese populations Jiang He
&bull; GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
&bull; Molecular epidemiology of diabetes in Chinese populations Weiping Jia
&bull; Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
&bull; Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
&bull; Genetic structure of Chinese population Li Jin
&bull; High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
&bull; Molecular genetics study of neural tube defect Hongyan Wang
&bull; Risk prediction using genetic variants in prostate cancer Jianfeng Xu
&bull; Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
&bull; Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时  间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹,高歌 (Shanghai, China);Tamara Adams (U.S.)
联系电话: 21-55664495 (Shanghai, China);336-713-7532 (U.S.)
回执邮箱: GWAS2009@gmail.com (Shanghai, China);tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)&bull; Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
&bull; Genetic epidemiology of skin cancer and breast cancer
&bull; Genome-wide association studies
&bull; Gene-environment interaction&bull; Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
&bull; Genetic epidemiology of hypertension
&bull; Gene-nutrition interaction of cardiovascular disease&bull; Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
&bull; Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
&bull; Genome-wide association studies
&bull; Genetic variants and association study&bull; Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People&rsquo;s Hospital, Shanghai Jiaotong University, Her major research area is:
&bull; Molecular endocrinology and diabetes&bull; Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
&bull; Genetic and molecular epidemiology of lung cancer and glioma
&bull; Genetics of metabolism diseases
&bull; Genetic markers for population genetics&bull; Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
&bull; Genetic and molecular epidemiology of lung cancer and glioma
&bull; Genetics of metabolic disease&bull; Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
&bull; Genetic and lifestyle predictors of cancer and other chronic diseases
&bull; Cohort study methodology
&bull; Incorporating biomarkers in risk prediction&bull; Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
&bull; Translational cancer research
&bull; Gene expression profiling
&bull; Cancer genome high-throughput sequencing&bull; Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
&bull; Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)&bull; Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
&bull; Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
&bull; Genetic susceptibility to cancer
&bull; DNA repair and apoptosis phenotype markers&bull; Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
&bull; Genetic epidemiology of prostate cancer
&bull; Genome-wide association and fine mapping analysis
&bull; Risk prediction using genetic markers and other clinicopathologic variables&bull; Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
&bull; Molecular epidemiology of smoking-related cancers
&bull; Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
&bull; Gene-environmental interaction between genetic markers and environmental factors&bull; S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
&bull; High-throughput genotyping and sequencing
&bull; Genetic epidemiology of prostate cancer&bull; Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
&bull; molecular and genetics of complex diseases&bull; Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
&bull; Molecular and genetics of cardiovascular diseases&bull; Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
&bull; Topic of presentation: Molecular epidemiology of stomach cancer

2024.05.24 广州实验室陈晔光课题组公开招聘

招聘信息,PC 端可以登陆 https://GZLAB.hotjob.cn 了解岗位相关情况。

2023.06.21 0 元体验降温仪!更有胎牛血清、重组抗体、培养瓶等好物限时促销

;优选序列,染色指数高。▼ 识别二维码立即咨询 ▼洁特生物三角培养摇瓶系列●滤膜盖设计,阻菌透气;●挡板设计,溶氧更充分;●PC
新冠重症:无创通气与高流量氧疗如何设置?看完就会了

2023.01.17 新冠重症:无创通气与高流量氧疗如何设置?看完就会了

(continuois postive airway prssure)双水平:S(spontaneous)、S/T(spontaneous/timed)、T(timed)、PC

2022.12.29 绝了!室友在寝室偷偷养细胞?状态竟然超好

;, Mozilla FireFox™, 或 Microsoft Edge™;2)仅适用于 PC 和 Mac 台式机 / 笔记本电脑,手机和平板电脑并不

2022.10.08 读博父子兵!南邮父子俩成同门,跟随同一导师读博

;for=pc题图来源:自制

2022.09.27 做麻了!用多孔板做实验,怎么才能拍出好 Figure?

软件可远程访问图像库,并可预约空余机时;一体化高清触摸屏和外置 mini-PC,智能化设计,节省空间,灵活度更高。如您对 Amersham

2020.06.01 2020中国国际防疫及防护物资交易会 · 郑州站

用PET/PC防雾卷材以及片材、密封条、拉链、抗静电剂以及其他生产医用防护服、医用口罩等重要原材料·生产设备:防护服压条机、口罩成型机、口罩压合机、口罩切边机、呼吸阀冲孔

2020.06.01 2020中国国际公共卫生安全 防控、防疫及防护物资交易会

用PET/PC防雾卷材以及片材、密封条、拉链、抗静电剂以及其他生产医用防护服、医用口罩等重要原材料。生产设备:防护服压条机、口罩成型机、口罩压合机、口罩切边机
上一页 1 2 3 ... 48 49 50 到第